Dipyridamole Articles
Boehringer's 2008 net sales jump 6.4%
24 April 2009
CombinatoRx' Synavive disappoints in Ph II trial
13 October 2008
CombinatoRx presents update on pipeline
4 August 2008
Spiriva and Micardis boost Boehringer's 2007 sales 8.8%, as profit jumps 4.8% to $2.8M
14 April 2008
Domestic vs JV drug prices in China differ
20 August 2007
Barr challenges Boeh Ing's Aggrenox patent
23 July 2007
B-I publishes key stroke prevention data
29 January 2007
Actavis launches five new products in USA
17 July 2006
CRx-102 shows efficacy in osteoarthritis study
3 July 2006
Record growth for Boeh Ing Japan
1 May 2006
Boeh Ingelheim starts two mega-trials
24 February 2003
Stroke prevention emerges from heart disease
10 January 2001
BI's Aggrenox OKed in USA
25 November 1999
BI granted a priority review for Aggrenox
4 March 1999
Greece: Industry Fury At Govt Price Moves
20 October 1997
Sanofi's Mid-term Pipeline "One Of The Most Promising
23 October 1995
Favorable Results From ESPS-2 Study
18 September 1995
Nippon Boehringer Ingelheim Marketing News
6 February 1995
Pharmacia's Fragmin After Bypass Grafting
10 October 1994
NEW HORIZONS FOR THE USE OF LMW HEPARIN
30 May 1994
BARR LABS REINTRODUCES TWO DRUGS
28 June 1993
Showing 1-28 of 28 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
